Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
In Vitro Drug Dissolution: Compendial Testing Models II01:09

In Vitro Drug Dissolution: Compendial Testing Models II

Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
In Vitro Drug Dissolution: Compendial Testing Models I01:13

In Vitro Drug Dissolution: Compendial Testing Models I

Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
Drug Dissolution: Requirements and Profile Comparison01:14

Drug Dissolution: Requirements and Profile Comparison

The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dissolution of Oral Solid Dosage Formulations: Surrogate Models and Real-time Release.

The AAPS journal·2025
Same author

An Optimization Approach Coupling Preprocessing with Model Regression for Enhanced Chemometrics.

Industrial & engineering chemistry research·2023
Same author

Stochastic analysis and modeling of pharmaceutical screw feeder mass flow rates.

International journal of pharmaceutics·2022
Same author

Hybrid QSPR models for the prediction of the free energy of solvation of organic solute/solvent pairs.

Physical chemistry chemical physics : PCCP·2019
Same author

How do formulation and process parameters impact blend and unit dose uniformity? Further analysis of the product quality research institute blend uniformity working group industry survey.

Journal of pharmaceutical sciences·2013
Same author

A material sparing test to predict punch sticking during formulation development.

Drug development and industrial pharmacy·2011
Same journal

Design and evaluation of a pump-free ultrasonic atomization-driven hollow microneedle array for transdermal drug delivery.

International journal of pharmaceutics·2026
Same journal

Predicting milling performance of pharmaceutical crystals from elastic modulus.

International journal of pharmaceutics·2026
Same journal

Lipid digestion- driven drug fate as a key determinant of SNEDDS performance: Mechanistic basis of absorption and in vitro- in vivo disconnect.

International journal of pharmaceutics·2026
Same journal

Redox-responsive nanomedicine beyond glutathione: harnessing reactive oxygen species and emerging endogenous triggers for precision drug delivery.

International journal of pharmaceutics·2026
Same journal

Preventing tablet defects through vacuum-assisted deaeration of a powder bed.

International journal of pharmaceutics·2026
Same journal

Approaches for enhancing bioavailability of macromolecular drugs.

International journal of pharmaceutics·2026
See all related articles

Related Experiment Video

Updated: Jun 12, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Coating uniformity assessment for colored immediate release tablets using multivariate image analysis.

Salvador García-Muñoz1, Daniel S Gierer

  • 1Pharmaceutical Development, Pfizer Global R & D, 445 Eastern Point Road, Groton, CT 06340, USA. salvador.garcia-munoz@pfizer.com

International Journal of Pharmaceutics
|June 23, 2010
PubMed
Summary
This summary is machine-generated.

Multivariate image analysis (MIA) offers a cost-effective, quantitative alternative to visual inspection for film-coated tablets. This technology accurately assesses coating levels and distribution, enhancing quality control in pharmaceutical manufacturing.

More Related Videos

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
07:05

Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section

Published on: June 20, 2025

Related Experiment Videos

Last Updated: Jun 12, 2026

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis
07:48

Tracking Drug-induced Changes in Receptor Post-internalization Trafficking by Colocalizational Analysis

Published on: July 3, 2015

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section
07:05

Correlative Optical Spectroscopy and Mass Spectrometry Imaging Methodology to Visualise Drug Distribution in a Soft Tissue Section

Published on: June 20, 2025

Area of Science:

  • Pharmaceutical Technology
  • Analytical Chemistry
  • Process Analytical Technology (PAT)

Background:

  • Visual inspection of film-coated tablets is subjective and lacks quantitative data.
  • Current methods for assessing coating uniformity and endpoint are often time-consuming and less precise.
  • Integrating quantitative analysis into the coating process aligns with Quality by Design (QbD) principles.

Purpose of the Study:

  • To introduce and validate Multivariate Image Analysis (MIA) as a quantitative tool for assessing film-coated tablets.
  • To determine the cosmetic endpoint of film-coating and quantify coating level and distribution.
  • To demonstrate the adaptability of MIA for both off-line and in-line quality control.

Main Methods:

  • Utilized digital images of film-coated tablets.
  • Applied multivariate latent variable methods, including Principal Components Analysis (PCA) and Projection to Latent Structures (PLS).
  • Developed a novel adaptive PCA approach for real-time, in-line image analysis within the coater.

Main Results:

  • MIA successfully provided quantitative assessment of coating level and distribution, replacing subjective visual inspection.
  • Coating distribution breadth increased with tablet scale, and coating material amount correlated with tablet surface area.
  • The adaptive PCA method effectively translated real-time webcam images into actionable indexes for process control.

Conclusions:

  • MIA is a robust, cost-effective tool for quantitative assessment of film-coated tablets, supporting QbD.
  • The technique provides objective data for determining the cosmetic endpoint and ensuring coating quality.
  • Adaptive PCA enables real-time, in-line monitoring and control of the film-coating process.